ArticleJHEP reports : innovation in hepatology2026
Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacy.
Thomas Michler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.